Menu

Webinar

Masterclass Live! How We Evaluate a Venture Deal

Watch an on-demand presentation hosted by Alumni Ventures’ Provo Ventures. In this session, you’ll discover how to evaluate a deal, walk through the process our investment team uses to invest in promising startups and learn how you, too, can invest in startups like this through Alumni Ventures’ Provo Ventures.

See video policy below.

During the session, we will discuss:

  • Home

    Determining if a prospective deal fits in with your overall diversification goals
  • Home

    Understanding the time horizon of venture investments
  • Home

    Performing due diligence and reviewing the typical types of materials available in a deal
  • Home

    Weighing some of the challenges, key risks, and how to factor into the ultimate decision
  • Home

    Tracking companies after investment and the purpose of portfolio monitoring
  • Home

    More details about Provo Ventures
About Alumni Ventures

Top 20 VC Investors in North America (2024)

#1 Most Active Venture Firm in the U.S. (2023)

#1 Most Active Venture Firm in the U.S. (2022)

World's Most Innovative Companies (2022)

Note: You must be accredited to invest in venture capital. Important disclosure information can be found at av-funds.com/disclosures. 

About your presenter

Matt Caspari
Matt Caspari

Managing Partner, Provo Ventures

Matt Caspari is a Managing Partner at Alumni Ventures, where he leads the Deep Tech, Georgetown (Potomac Ventures) and UC Berkeley (Strawberry Creek Ventures) funds. He invests in mission-driven founders developing groundbreaking technologies. His investments encompass a diverse range of sectors, including AI, agriculture, aviation, battery technology, cybersecurity, direct air capture of CO2, energy generation, longevity, and robotics. Prior to Alumni Ventures, Matt gained operational experience as a two-time venture-backed founder/CEO and as a leader of the innovation team at Nike. He was the founding CEO of Aurora Biofuels, a deep tech venture that grew to 100+ employees, secured over $100 million in funding and was acquired by Reliance Industries. In earlier roles, Matt served as a strategic management consultant at Cambridge Pharma Consultancy, later acquired by IMS Health, and gained experience on the M&A team at Bloomberg. He holds a BS in Biochemistry from Georgetown University and an MBA with a Certificate in Entrepreneurship from UC Berkeley.

Webinar Registration

Follow us

AV Headquarters
670 N. Commercial Street
Suite 403
Manchester, NH 03101
General inquiries: [email protected]

Press inquiries: [email protected]

603-518-8112

Follow us

Neither Alumni Ventures nor any of its funds are sponsored by, affiliated with, or otherwise endorsed by any university. For further details see our Legal & Privacy Policy.

Video Policy: By consuming this content I acknowledge that I may be considering an investment with AV funds for my own or my client’s account. I agree that information contained herein may not be relied upon or used for any other purpose. Offers to purchase securities are only made through formal offering documents, which describe risks (which are significant), terms, and other important information that must be considered before an investment decision is made. To see Important Disclosure Information, visit: https://av-funds.com/disclosures.

Testimonial/Endorsement Policy: Testimonials/Endorsements were provided by the participants without compensation, but each participant has a relationship with Alumni Ventures (AV) from which they benefit. All views expressed are the individual’s own and do not represent the experience of all AV fund investors or companies in which AV funds invest. Please note that testimonials are no guarantee of future performance or success. Any provider of an endorsement that is affiliated with a portfolio company Alumni Ventures has received investment funding from AV, and may in the future seek and/or receive additional funding from AV. This circumstance constitutes a conflict of interest. Providers of testimonials or endorsements were not chosen at random or according to any objective basis, but rather on the basis of their relationship with AV.

Investor Portal Update Policy: Investor portfolio data is updated once per quarter in the AV Investor Portal.

Alumni Ventures is America’s largest VC firm for individual investors based on the combination of total capital raised, number of investments, and number of investors of leading VC firms as reported by Pitchbook and other publicly available information reviewed by AV.

(1) Internal Rate of Return (IRR) for AV Funds is net of management fees and incentive allocations applied to amounts distributed to investors, and gross of incentive allocations applicable to unrealized gains on investments held by AV Funds. IRR for AV Funds includes uninvested cash, unrealized investments, and amounts distributed to investors. The IRR shown for the Russell 2000 indices are gross of fees because indices are not managed investments, and it is not possible to invest directly in an index. For additional information see av-funds.com/disclosures. All investment involves risk, including risk of loss. Past performance is not necessarily indicative of future results. For more information on AV Funds’ investment returns, please see here.

Not an offer to sell, or a solicitation of an offer to purchase, any security. Such offers are only made pursuant to the formal offering documents for the fund, that describe the risks (which are significant), terms, and other important information that must be considered before an investment decision is made.
To see additional risk factors and investment considerations, visit: https://av-funds.com/disclosures.

Please click here to view additional investor policies.

© 2024, Alumni Ventures. All rights reserved.